Target intelligence / Profile preview

T cell receptor beta variable 10-1 (TRBV10-1)

Target
TRBV10-1
Molecular classification
Receptor, Immunoglobulin superfamily, Variable region of T cell receptor beta chain
01

Overview

T cell receptor beta variable 10-1 (TRBV10-1) is a variable region-encoding gene segment within the human T cell receptor beta (TRB) locus, which encodes the variable domain of the beta chain in the heterodimeric T cell receptor (TCR) complex found on the surface of T cells[1][5]. The beta chain, which is assembled from distinct variable (V), diversity (D), and joining (J) gene segments through somatic V(D)J recombination, contributes to the antigen-binding specificity of TCRs by forming the complementarity-determining regions (CDRs)—mainly CDR1, CDR2 (germline-encoded), and CDR3 (recombination-generated)[1][5]. TCRs, including those containing a TRBV10-1 variable segment, allow T lymphocytes to recognize peptides presented by major histocompatibility complex (MHC) molecules, playing a central role in adaptive immunity[1][2]. The variable TRBV gene segments confer antigen diversity and specificity, but are not directly therapeutic targets themselves. Rather, detection of TRBV usage (including TRBV10-1) is used in immunology and oncology research as a biomarker for clonal T cell expansion (such as in leukemia, infection, or response to immunotherapy)[1][5]. There are no known drugs that specifically bind or modulate TRBV10-1 itself, nor are there well-established safety concerns unique to TRBV10-1. The segment’s main relevance is in its contribution to the molecular diversity and specificity of the TCR β chain[5].

Other names
TCRBV10S1TCRBV12S2A1TTCRBV12S2TRBV101T cell receptor beta variable 10-1 (gene/pseudogene)V segment translation product
02

Biological functions

Antigen recognitionImmune responseSignal transduction
03

Disease associations

CancerInfectionAutoimmunityOther immune-related diseases
04

Biomarkers

T cell clonality (TCR repertoire sequencing)Immune response monitoring in cancer, autoimmune conditions, infectious diseases

Beyond the preview

Go deeper on T cell receptor beta variable 10-1 (TRBV10-1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on T cell receptor beta variable 10-1 (TRBV10-1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call